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AbSTrAcT
Objective: We explored the planned cesarean to vaginal delivery at the risk of fetal or neonatal death or serious neonatal 
morbidity in women with twin pregnancies. 
Material and methods: Three hundred and forty-three pregnant women were divided into planned cesarean delivery 
(PCD) and vaginal delivery (PVD) groups (208 vs 135). In the planned-cesarean-delivery group, the rate of cesarean delivery 
was 98.82%. Meanwhile, the rate of vaginal delivery was 51.27% in PVD group. 
results: Women in the PCD group delivered earlier than that in the PVD group. However, the composite primary outcome 
of the PCD group was like that of the PVD group. Certainly, the odds ratio of planned cesarean delivery and confidence 
interval of the PCD group was also like those of the PVD group. 
conclusions: The risk of fetal or neonatal death or serious neonatal morbidity of planned-vaginal-delivery was like those 
of planned-vaginal-delivery in pregnant women with twin pregnancies.
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InTrOducTIOn
Twin gestations accounts for 3% of all deliveries and has 
different risk characteristics than singleton gestations [1, 2]. 
It has been reported that in recent years, the cesarean sec-
tion rate of multiple pregnancies has gradually increased 
to more than 70% [3]. The main reason for the rise of cae-
sarean section (CS) rate in the world is maternal-choice CS 
(MCCS) [4]. Twin pregnancies appear to be an independ-
ent risk factor for cesarean births after induction of labor, 
but more than three-quarters of inductions culminated in 
vaginal delivery [5]. Implementation of the National Insti-
tute for Health and Care Excellence (NICE) guidance on the 
antenatal management of uncomplicated twin pregnancies 
contributed to significant reduction (>70%) in stillbirth has 
been noted in twin pregnancies in UK [6].
However, compared with singleton pregnancies, compli-
cations of gemellary pregnancies are obviously higher [7]. 
During gemellary pregnancies, it is more likely to have abor-
tions, fetal malformations, polyhydramnios, preeclampsia 
and premature delivery, etc. [8]. During the stages of labor, 
complications such as dystocia, prolapse of cord and post-
partum hemorrhage are more likely to occur [9]. As recent 
cesarean section rates in China are abnormally increasing, 
most gemellary pregnancies would be performed in the way 
of caesarean sections [10]. However, a gemellary pregnancy 
is not the absolute indication for cesarean delivery. Further-
more, when the heads of two fetuses or the first fetus head 
appears, vaginal delivery is principally feasible. Vaginal deliv-
ery is demanded by some gemellary pregnant women [11]. 
The selection of delivery time has no single standard 
by now. Generally, most gemellary pregnant women with-
out complications would be admitted to hospital between 
the 36th~39th weeks [12]. The lowest fetal mortality and 
neonatal mortality rate occur between the 38th and 39th 
weeks, respectively. Consequently, it is generally suggested 
that gemellary pregnancies should be terminated before 
the 39th week. At present, caesarean sections are regarded 
as a relatively effective method for high risk pregnancy 
women and has been widely accepted and employed [13]. 
As society is constantly advancing and medical modes are 
continuously changing, rates of caesarean births are ascend-
ing steadily [14].
The Twin Birth Study, a recent randomized controlled 
trial of 2804 women with twin pregnancies, showed that 
the first twin presented in cephalic position to planned 
vaginal delivery or planned cesarean. All in all, there were 
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no differences in neonatal and maternal outcome between 
the planned vaginal delivery and planned cesarean groups 
[15]. However, the design of the Twin Birth Study has always 
been controversial [16]. In this study, most women delivered 
shortly after the 32 weeks. Prematurity has a great influence 
on the neonatal outcomes, so it may include the influence 
of the way of full-term planned delivery. The subgroup of 
women that was randomized after 37 weeks was small and 
it was not clear which was the best method of delivery in 
twin pregnancy at term, although the less morbidity was 
observed after planned caesarean delivery. Whether the 
outcomes of the Twin Birth Study are completely applicable 
to other settings are still unknown [17].
 Cesareans are not a physiological suitable means of 
pregnancy. As a traumatic surgery, it has many disadvan-
tages and would bring about some problems for women. 
Besides, women after caesarean are more likely to have 
massive haemorrhaging, wound infection, scarred uterus or 
various complications [18]. As far as women who have subse-
quent pregnancies are concerned, they are confronted with 
the issue how to select their subsequent pregnancy meth-
ods [12]. This study was carried out to compare planned 
cesarean to vaginal delivery at the risk of fetal or neonatal 
death or serious neonatal morbidity in pregnant women 
with twin pregnancies. 
MATerIAl And MeTHOdS
Study design
Women permitted to participate in the study had preg-
nancies with twins ranging from 32 weeks to 39 weeks, with 
the head of the first twin appearing earlier than the second 
during birth and with the two fetuses staying alive with 
weight from 1500 g to 4000 g, which was authenticated 
via ultrasonography within a week prior to randomiza-
tion. Women were recruited with pregnancies as early as 
32 weeks of gestation inasmuch as the number of women 
with twins intend to start a choice of the method of delivery 
at this time and a host of twins are born prematurely.
Study oversight
Women with the following conditions were excluded 
from the study: monoamniotic twins, the number of fetuses 
reduced at more than 13 weeks of gestation, anomalous fe-
tus that is fatal, contraindication to labor or vaginal delivery, 
and prior participation in the Twin Birth Study.
Treatment
Our protocol, whose full text is available at NEJM.org, 
was approved by the research ethics committee at each 
participating center. All women participants, prior to the 
enrolment, provided the informed consent in written form. 
The first, second and last authors oversee the exactitude and 
integrity of all data and the correspondence of the report 
with integrity.
Those participating were distributed to planned cesar-
ean delivery (PCD) and vaginal delivery (PVD) groups at ran-
dom. Randomization was kept under control at the Centre 
for Mother, Infant, and Child Research at Sunnybrook Health 
Sciences Centre in Toronto with the assistance of a com-
puterized program of randomization which was layered in 
line with parity (0 vs ≥ 1) and gestational age (224 days to 
237 days, 238 days to 258 days, or 259 days to 272 days). 
Table 1. Characteristics of pregnant woman at baseline
characteristic cesarean deliver (n = 208) Vaginal delivery (n = 135)
Previous cesarean section 7 (3.37%) 5 (3.70%)
Age ≥ 30-year age 87 (41.83%) 59 (43.70%)
Mean age 31.6 ± 0.9 31.9 ± 0.7
32nd week–33rd week 61 (29.32%) 41 (30.37%)
34th week–36th week 101 (48.56%) 67 (49.63%)
37th week–38th week 46 (22.12%) 27 (20.00%)
Fetal weight
First twin 1179 ± 411 1184 ± 409
Second twin 1166 ± 406 1176 ± 405
chorionicity
Dichorionic and diamnionic 142 (68.27%) 91 (67.41%)
Monochorionic and diamnionic 57 (27.40%) 38 (28.15%)
Unknown 9 (4.32%) 6 (4.44%)
Not in labor 181 (87.02%) 119 (88.15%)
Membranes ruptured 11 (5.29%) 7 (5.19%)
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Experienced staff members accumulated data from the 
medical records at each participating center and kept them 
on file, following labor, on standardized forms for data col-
lection. Participating centers made an evaluation of the 
growth and well-being of fetuses by means of ultrasonog-
raphy every four weeks at the minimum by stress free or 
biophysical profile test twice/week if need be. Preparations 
were made for possible cesarean sections within thirty min-
utes as the need arose; and at the time of planned vaginal 
delivery members in the hospital related to anesthesia, 
obstetrics and nursing were placed on standby. 
Alternative delivery by way of either cesarean section 
(PCD group) or labor induction (PVD group) was organized 
between 264 to 272 days of gestation, so far as there was 
some evidence that at this gestational — age window peri-
natal conditions would yield the best possible results. Pro-
vided the first twin was brought into the world through 
vaginal means by a woman in the planned-cesarean group, 
the second twin would be delivered in the same manner, if 
logistically possible. In regards to women who were sched-
uled to have a vaginal delivery, it was expected that no 
less than 60% would give birth to both twins by vaginal 
means. At the time of delivery, there was a reassessment of 
the pregnancy; in case of a contraindication to labor or vagi-
nal delivery, both twins would be born via caesarean section. 
Standard methods were utilized in case of induced labor, but 
for women with a previous caesarean section, advocacy of 
prostaglandins was not permitted. 
Constant monitoring of the fetal heart rate by elec-
tronic means was approved in course of active labor. The 
obstetrician was authorized to make a decision regarding 
the application of oxytocin and epidural analgesia. Follow-
ing the first twin birth, it would be advisable to make use 
of ultrasonography to examine the state of the second 
twin. In the event the twin would be born with the head 
appearing first, amniotomy was postponed until the head 
was engaged and natural vaginal delivery was planned, 
only when an unsatisfactory position necessitated the 
usage of forceps or vacuum extraction. Assuming the 
second twin did not remain in the cephalic presentation, 
the obstetrician was free to decide about the optimum 
method of delivery.
Those scheduled to have a vaginal delivery were accom-
panied by a competent obstetrician adept at vaginal twin 
delivery. This was interpreted a priori, an obstetrician who 
themselves had at vaginal twin delivery and whose depart-
ment head saw eye to eye with this judgment. Prior to the 
recruitment at each center, a number code was assigned 
to each of the competent obstetricians who considered 
themselves qualified in vaginal twin birth, as well as their 
years of service with vaginal twin delivery and information 
was kept on file. In addition, collection of information about 
similar items for other clinicians present during delivery 
was also made. 
Infants are born with positive-pressure ventilation, 
tracheal intubation, oxygen, intravenous therapy, blood 
transfusion, surfactant, or a combination of these therapies, 
if needed. An assessment of intracranial pathology was 
made by means of neonatal ultrasonography if so, specified 
in a clinical sense.
Outcomes
Regarding the current analysis, both mothers and their 
neonates were kept track of until 28 days after the delivery. 
The principal outcome was a combination of mortality of 
fetuses or neonates or life-threatening diseases for neo-
nates. Assessment of neonatal mortality was made between 
day 1 and day 27 following the birth. Life-threatening dis-
eases for neonates were interpreted as the following: birth 
trauma (spinal cord injury, basal or depressed skull fracture, 
fracture of a long bone, harm done to a peripheral nerve 
manifesting itself within 72 h after birth or at discharge, sub-
dural or intracerebral hemorrhage substantiated through 
the agency of ultrasonography, CT, or MRI, APGAR score 
of no more than 4 to 5 min, coma, stupor, or slowed-down 
response to pain, minimum of two seizures before 72 h 
since birth, requirement of assisted ventilation by way of 
an endotracheal tube interpolated within 72 h following 
birth and kept in place for 24 h at the minimum, septicemia 
authenticated by way of blood culture or meningitis au-
thenticated by means of cerebrospinal fluid culture within 
72 h after birth, necrotizing enterocolitis, interpreted as 
intestinal perforation, pneumatosis intestinalis, or air in 
the portal vein diagnosed via surgery or radiography, bron-
chopulmonary dysplasia, interpreted as the requirement for 
additional oxygen at a postnatal gestational age of 36 weeks 
and authenticated by way of radiography, intraventricular 
hemorrhage or cystic periventricular leukomalacia. Data 
about newborn babies with the principal outcomes were 
evaluated with such information as the assigned group and 
mode of delivery (if applicable) kept dark by an adjudica-
tion committee.
Statistical analysis
Another result was an amalgam of death of a mother 
or mother’s grave illness within 28 days following child-
birth, interpreted as the following: death, hemorrhage 
(blood loss ≥ 1500 mL, need for blood transfusion, or need 
for dilation and curettage after delivery), laparotomy, 
genital tract injury (need for hysterectomy; vulvar or 
perineal hematoma requiring evacuation; broad-ligament 
hematoma authenticated by means of ultrasonography, 
CT, or MRI; intraoperative damage to the bladder, ureter, 
or bowel requiring repair; fistula involving the genital 
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tract; or third-degree or fourth-degree perineal laceration 
involving the anal sphincter or mucosa, thromboembo-
lism requiring anticoagulant therapy, systemic infection, 
serious illness that is life-threatening, wound infection 
that calls for prolonged hospitalization, readmission to 
the hospital, or repeated treatment as an outpatient, 
wound dehiscence or breakdown; or other grievous ma-
ternal complication. Other detrimental factors except 
morbidity defined beforehand were supposed to be pre-
sented to the independent board for monitoring data 
and safety.
Subordinate results to be presented later encompassed 
death, an unsatisfactory neurodevelopmental outcome for 
children two years of age and troublesome urinary, fecal, or 
flatal incontinence for mothers two years following child-
birth. There were additional results for mothers, inclusive 
of contentment with the mode of delivery, breast-feeding, 
quality of life, tiredness and melancholia. 
The data are expressed as the mean ± standard deviation 
and conducted using SPSS 17.0 (SPSS, Inc., Chicago, IL, USA). 
Statistical analysis was performed where appropriate, and 
the Student-Newman-Keuls method was used for pairwise 
Table 2. Characteristics of labor and delivery for pregnant woman
characteristic cesarean deliver (n = 208) Vaginal delivery (n = 135)
Mode of delivery
Cesarean 187 (89.90%) 51 (37.77%)
Vaginal and cesarean 2 (0.96%) 7 (5.19%)
Vaginal for both 19 (9.13%) 77 (57.04%)
Timing of cesarean section
Before the onset of labor 109 (52.40%) 19 (14.07%)
During labor 65 (31.25%) 42 (31.11%)
No cesarean section 34 (16.35%)  74 (54.81%)
Presentation at delivery
cephalic presentation
Cephalic and noncephalic presentation 142 (68.27%) 91 (67.41%)
Noncephalic and cephalic or noncephalic presentation 57 (27.40%) 38 (28.15%)
Gestational age at delivery 9 (4.32%) 6 (4.44%)
Not in labor 181 (87.02%) 119 (88.15%)
Membranes ruptured 11 (5.29%) 7 (5.19%)
Gestational age at delivery of first twin
Mean age 
32nd week–33rd week 11 (5.29%) 4 (2.96%)
34th week–36th week 84 (40.38%) 58 (42.96%)
37th week–38th week 109 (52.40%) 69 (51.11%)
> 39th week 4 (1.92%) 4 (2.96%)
Time from randomization to delivery of first twin 12.2 ± 12.1 days 13.4 ± 12.2 days
Interval between deliveries 3.3 ± 9.6 min 10.2 ± 17.4 min
Use of antenatal glucocorticoids after randomization 25 (12.02%) 14 (10.37%)
chorionicity at birth
Dichorionic and diamnionic 149 (71.63%) 97 (71.85%)
Dichorionic and diamnionic 42 (20.19%) 30 (22.22%)
Dichorionic and diamnionic 1 (0.48%) 1 (0.74%)
Unknown 16 (7.69%) 7 (5.19%)
Use of anesthesia or analgesia 201 (96.63%) 95 (70.37%)
Regional 192 (95.52%) 73 (76.84%)
General 13 (6.47%) 6 (6.32%)
Other 4 (1.99%) 10 (10.52%)
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comparison. P < 0.05 was considered to indicate a statisti-
cally significant difference.
reSulTS
characteristics of pregnant woman at baseline
There were 343 pregnant women who were randomly 
divided into PCD and PVD groups (208 vs 135) between 
October 2013 and March 2015. Table 1 showed that base-
line characteristics of the two study groups were similar. 
The PCD group [162/208 (77.88%)] and the PVD group 
[108/135 (80.00%)] underwent randomization between 
224 days and 258 days of gestation, respectively.
characteristics of labor and delivery  
for pregnant woman
As shown in Table 2, the labor and delivery outcomes for 
all women were as follows: the planned-cesarean-delivery 
group, 187 (89.90%) pregnant women, 2 (0.96%) pregnant 
women and 19 (9.13%) pregnant women appeared cesar-
ean for both infant, Vaginal and cesarean, and Vaginal for 
both, respectively; in the planned-vaginal delivery group, 
51 (37.77%) pregnant women, 7 (5.19%) pregnant women 
and 77 (57.04%) pregnant women appeared cesarean for 
both infant, Vaginal and cesarean, and Vaginal for both, 
respectively. Timing of cesarean sections were higher in 
the planned-cesarean-delivery group than those in the 
planned-vaginal delivery group. There were no significant 
Table 3. Pregnancies outcomes
characteristic cesarean deliver (n = 208) Vaginal delivery (n = 135)
No. of fetuses or infants included in analysis 418 271 
Primary outcome 8 (1.91%) 6 (2.21%)
Gestational age
32nd week–33rd week 6 4 
34th week–36th week 2 2 
37th week–38th week 0 0 
Birth trauma 1 0
Long-bone fracture 0 2 
Other bone fracture 1 0 
Facial-nerve injury at 72 h of age or at discharge 0 1
Intracerebral hemorrhage 1 1
Apgar score < 4 at 5 min 1 4
Abnormal level of consciousness
Stupor or decreased response to pain 4 2
Hyperalert, drowsy, or lethargic 0 1
Assisted ventilation for ≥ 24 h by means of endotracheal tube, 
inserted within 72 h after birth 0 2
Cystic periventricular leukomalacia 1 0
differences in other factors between the planned-vaginal 
delivery group and planned-vaginal delivery group. 
Pregnancies outcomes
As shown in Table 3, the primary outcome was notably 
associated with gestational age at randomization. However, 
other factors between the PVD group and the PCD group 
were not related with primary outcome. 
Pregnant outcomes
There was no significant difference in the frequency of 
the maternal composite outcome between the planned-ce-
sarean-delivery and planned-delivery groups (Tab. 4). Dur-
ing the trial, all adverse events documented were meas-
ured composing the morbidity component of the primary 
outcome. However, there was no other adverse outcome 
reported to the data and safety monitoring board.
dIScuSSIOn
With the development of assisted reproductive technol-
ogy, ratio of gemellary pregnancy worldwide is significantly 
increasing and distocia is more challenging to modern Ob-
stetrics and Gynaecology [18]. In recent years, vaginal delivery 
rates of twins were decreasing while cesarean section rates 
were increasing year by year [19]. It was reported that in Chi-
na, vaginal delivery rates of twins in 2010 were 78.45% [10]. 
As a result, how to select a suitable delivery method and 
reduce cesarean section rates is an issue that needs to be 
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solved urgently. In the present study, the results verified 
162/208 (77.88%) pregnant women in the PCD group and 
108/135 (80.00%) pregnant women in the PVD group un-
derwent randomization between 224 days and 258 days 
of gestation. 
When pregnant women feel hyperinflation in abdo-
men, expiatory dyspnea or serious illness, pregnancy 
should be terminated [20]. Furthermore, when women 
have premature rupture of fetal membranes or about 
to give birth during 28th–34th week, pregnancy should 
be terminated after fetal lung maturating [10]. Finally, 
pregnancy termination should be considered when com-
plications occur, and pregnancy cannot be continued 
[13]. When the expected date of confinement reaches 
but delivery does not occur, women should be admitted 
to hospital and termination of the pregnancy should be 
considered [7]. Like a singleton pregnancy, delivery time of 
a gemellary pregnancy should comprehensively consider 
maternal complications and fetal situations in the uterus 
[21]. When the intrauterine environment is obviously not 
suitable to fetus growth and this condition cannot be 
improved by intrauterine therapy, it is the appropriate 
time to terminate the pregnancy [22]. Therefore, deliv-
ery time is dependent on specific conditions of pregnant 
women. Physician should communicate with women and 
their families as well as confirm gestational weeks. The 
present study showed that 87 (89.90%) pregnant women 
of the planned-cesarean-delivery group appeared cesar-
ean for both infant and 77 (57.04%) pregnant women of 
the planned-vaginal delivery group appeared vaginal for 
both infants. The timing of cesarean sections were higher 
in the PCD group than those of the PVD group.
In recent years, with rapid advances of medical technol-
ogy, cesarean techniques are significantly improving and 
rates of cesareans in China are continuous increasing [10]. 
However, cesareans may cause changes of uterus position 
or anteversion of uterus. As uterine contraction at uterine 
incision is weak, cesareans would seriously affect subse-
quent delivery [23]. Compared with normal labor, cesareans 
produce more bleeding and involution of uterus is slower 
[24]. Meanwhile, lactation and discharge of meconium for 
newborns delay while peak time of jaundice are later and 
more serious. Moreover, it would increase the possibilities 
of maternal and neonatal complications [25]. Consequently, 
the medical field is still confronted with the issue of how to 
select subsequent deliveries after a cesarean section. In the 
present study, significantly related to the primary outcome 
was gestational age at randomization in two groups. 
In conclusion, these data indicate that there were no 
benefits of planned cesarean section with the delivery of 
twins between 32 and 38 weeks of gestation in compari-
son to planned vaginal delivery, if the first twin was in the 
cephalic presentation. The risk of fetal or neonatal death 
or serious neonatal morbidity of planned-vaginal-delivery 
was like those of planned-vaginal-delivery in pregnant 
woman with twin pregnancy.
Table 4. Pregnant outcomes
characteristic cesarean deliver (n = 208) Vaginal delivery (n = 135)
Death or serious maternal morbidity 14 (6.7%) 8 (5.93%)
Hemorrhage 14 (6.73%) 8 (5.93%)
Blood loss ≥ 1500 mL 5 (2.04%) 4 (2.96%)
Blood transfusion 12 (5.77%) 8 (5.93%)
Dilation and curettage of uterus after delivery 3 (1.44%) 3 (2.22%)
Laparotomy 2 (0.96%) 1 (0.74%)
Genital tract injury 1 (0.48%) 1 (0.74%)
Perineal third- or fourth-degree tear involving anal sphincter 0 1 (0.74%)
Thromboembolism requiring anticoagulant therapy 0 2 (1.48%)
Infection, excluding wound infection 2 (0.96%) 1 (0.74%)
Wound infection 7 (3.37%) 2 (1.48%)
Infection requiring prolongation of hospital stay 5 (2.04%) 2 (1.48%)
Infection requiring readmission to hospital 2 (0.96%) 1 (0.74%)
Infection requiring repeated treatment as an outpatient 5 (2.04%) 1 (0.74%)
Wound dehiscence or breakdown 14 (6.73%) 8 (5.93%)
Major serious or life-threatening medical illness 3 (1.44%) 0
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